FDA approves Moderna's new Covid shot for seniors, at-risk
THE U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements.
The vaccine has also been approved for people aged 12 to 64 with at least one or more underlying risk factors, Moderna said in a statement.
The Department of Health and Human Services, under the leadership of long-time vaccine skeptic Robert F. Kennedy Jr., is increasing regulatory scrutiny on vaccines.
The FDA said on May 20 it planned to require drugmakers to test their COVID booster shots against an inert placebo in healthy adults under 65 for approval, effectively limiting them to older adults and those at risk of developing severe illness.
The Moderna vaccine, branded mNEXSPIKE, can be stored in refrigerators rather than freezers, to offer longer shelf life and make distribution easier, especially in developing countries where supply-chain issues could hamper vaccination drives.
The Centers for Disease Control and Prevention, which Kennedy also oversees, said on Thursday that COVID vaccines remain an option for healthy children when parents and doctors agree that it is needed, stopping short of Kennedy's announcement days earlier that the agency would remove the shots from its immunization schedule.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
17 hours ago
- The Star
Watchful of summer Covid-19 resurgence, Korea urges older adults to get vaccinated
Head of the Central Disaster and Safety Countermeasures Headquarters, Lee Han-kyung, visits a clinic in Cheongju, North Chungcheong Province, and inspects hospital beds on Monday (May 26, 2025). - Photo: Yonhap SEOUL: The South Korean government is closely monitoring Covid-19 resurgences in regional neighbors including Hong Kong, China and Thailand, amid growing worries that a summer resurgence may hit the country again this year. At a Central Disaster and Safety Countermeasures Headquarters meeting Friday (May 30), Director Lee Han-kyung warned of worsening Covid-19 trends abroad. "In regions close to us — Hong Kong, China and Thailand — Covid-19 infections are rising, and this is a cause for concern," Lee said at the meeting. He urged senior citizens aged 65 and above, as well as residents in high-risk facilities, to get vaccinated, stressing that vaccination is key to preventing severe illness and death. According to government data, recent overseas Covid-19 cases are showing a noticeable uptick. In Hong Kong, confirmed cases for the week of May 11 to 17 totalled 977, exceeding the country's previous summer peak of 796. China's rate of positivity Covid-19 test results is steadily climbing toward last year's peak of 21.1 percent, while in Thailand, more than 65,000 new cases were reported in the three weeks following the Songkran holiday in April. Despite the global trend, the number of new Covid-19 cases in Korea remained at around 100 each week over the past month. Currently, South Korea estimates the number of confirmed cases in select hospitals on a weekly basis. Still, the government is taking a proactive stance in consideration that domestic cases last year surged sharply from late July to mid-August. Weekly confirmed cases jumped from 456 in the fourth week of July to over 1,400 by mid-August in 2023. To mitigate potential risks, health authorities have extended the vaccination period for high-risk groups until June 30, two months beyond the initial April 30 deadline. The Korean Medical Association also issued a public advisory, pointing to the seasonal temperature shifts, increased domestic and international travel and a noticeable drop in personal hygiene practices such as hand-washing. It recommended six precautionary measures: maintaining personal hygiene, wearing masks, prompt response to symptoms, testing for high-risk individuals and recent international travellers, getting vaccinated and improving indoor ventilation. Recalling difficulties caused by last summer's surge, the association emphasised that preventive habits such as hand-washing and mask-wearing remain crucial. - The Korea Herald/ANN
Sinar Daily
21 hours ago
- Sinar Daily
Number of obese and overweight teenagers predicted to rocket
In a major new review of the health and wellbeing of adolescents, experts said some main drivers of ill-health among teenagers have switched from cigarettes and alcohol to weight gain and mental health problems. 01 Jun 2025 08:02am In a major new review of the health and wellbeing of adolescents, experts said some main drivers of ill-health among teenagers have switched from cigarettes and alcohol to weight gain and mental health problems. - Photo illustrated by Sinar Daily LONDON - Almost half a billion teenagers around the world will be overweight or obese by 2030, experts predicted as they warned that adolescent health is at a "tipping point', PA Media/dpa reported. In a major new review of the health and wellbeing of adolescents, experts said some main drivers of ill-health among teenagers have switched from cigarettes and alcohol to weight gain and mental health problems. They warned that mental health among teenagers has seen a "significant decline' over the past three decades, which was exacerbated by the Covid-19 crisis. And they projected that 464 million teenagers around the world will be overweight or obese by 2030 - 143 million more than in 2015. But the Lancet Commission on Adolescent Health and Wellbeing pointed out: "In terms of health risks, substance use (specifically tobacco and alcohol) has declined in every region.' The experts on the commission said action is needed to tackle threats to adolescents' health and wellbeing. They warned that progress in teenage health has "lagged well behind' the improvements that have been made in the health and development of young children - with these benefits being at risk of being "undermined' with increased ill-health in teenagers. They added that current funding is "not proportionate with the magnitude of the challenge'. They wrote: "Adolescence can no longer be ignored... the time to act is now.' The authors of the report also highlighted how the shift towards a "more digital world' could have a "profound impact on young people's future health and wellbeing'. But they warned against "overly restricting' access, saying there needs to be a balance, highlighting that the online world offers teenagers new opportunities for social interaction, education, employment and health promotion. Meanwhile, they pointed out that this generation of teenagers is the first to grow up among harsher climate conditions. "Today's adolescents are the first cohort of humans who will live their entire life experiencing the growing reverberations of climate change,' they wrote. Commission co-chairwoman Professor Sarah Baird, from George Washington University in the US, said: "The health and wellbeing of adolescents worldwide is at a tipping point, with mixed progress observed over the past three decades. "Whilst tobacco and alcohol use has declined and participation in secondary and tertiary education has increased, overweight and obesity have risen by up to eight-fold in some countries in Africa and Asia over the past three decades, and there is a growing burden of poor adolescent mental health globally. "Additionally, the challenges faced by the world's adolescents are at risk of being exacerbated by emerging global issues including climate change, world conflicts and a rapid transition to a more digital world. "Investing in the health and wellbeing of young people is crucial for safeguarding our collective future.' The authors of the commission's report point out that "investment in adolescent health will become increasingly important throughout the 21st century', adding: "As populations age and fertility rates fall in even the poorest countries, ensuring the health and wellbeing of adolescents will be crucial to all countries' health and prosperity.' - BERNAMA-PA Media/dpa More Like This
Free Malaysia Today
a day ago
- Free Malaysia Today
US FDA approves Moderna's next-gen Covid vaccine
Moderna's CEO Stephane Bancel said the approval provides a key tool to protect those at high risk of severe Covid-19. (EPA Images pic) CAMBRIDGE : The US food and drug administration has approved Moderna's next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements. The vaccine has also been approved for people aged 12 to 64 with at least one or more underlying risk factors defined by the Centers for Disease Control and Prevention, Moderna said in a statement. The company said it expects to have the vaccine, called mNEXSPIKE, available for the 2025-2026 respiratory virus season. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from Covid-19,' CEO Stephane Bancel said in the statement. The department of health and human services, under the leadership of long-time vaccine sceptic Robert F. Kennedy Jr., is tightening regulatory scrutiny on vaccines. The FDA said on May 20 it planned to require drugmakers to test their Covid booster shots against an inert placebo in healthy adults under 65 for approval, effectively limiting them to older adults and those at risk of developing severe illness. The Moderna vaccine can be stored in refrigerators rather than freezers, to offer longer shelf life and make distribution easier, especially in developing countries where supply-chain issues could hamper vaccination drives. The Centers for Disease Control and Prevention, which Kennedy also oversees, said on Thursday that Covid vaccines remain an option for healthy children when parents and doctors agree that it is needed, stopping short of Kennedy's announcement days earlier that the agency would remove the shots from its immunisation schedule. The CDC announcement eases investor concern to some extent, analysts say, as it keeps the existing framework for older adults and at-risk people who generally seek out the shots. FDA leaders have said 100 million to 200 million Americans would still be eligible for annual shots. Moderna is betting on its newer messenger RNA vaccines as it grapples with waning demand for its original Covid vaccine Spikevax and lower-than-expected uptake of its respiratory syncytial virus vaccine. The approval for mNEXSPIKE was based on late-stage trial data, which showed the shot was not inferior in efficacy compared to Spikevax in individuals aged 12 years and older. The shot also showed superior efficacy compared to Spikevax in adults 18 years of age and older in the study. Kennedy has kickstarted a major overhaul of health departments, laying off thousands of employees to align with President Donald Trump's goal of dramatically shrinking the federal government. This has further ignited worries about potential disruptions to the regulatory review of treatments and vaccines. The CDC's outside panel of vaccine experts in April discussed recommending the booster shots only for populations at risk of severe Covid-19 for the upcoming immunisation campaign. The FDA approved Novavax's Covid vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness. Conditions that constitute additional risk range from illnesses such as diabetes and heart disease to behaviours like physical inactivity and substance abuse, according to the CDC. While Moderna's shots, as well as Pfizer-BioNTech's Comirnaty, are mRNA-based, Novavax's vaccine is protein-based and takes longer to manufacture. Moderna this month withdrew an application seeking approval for its flu-and-Covid combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot.
